首页 > 最新文献

Nephrology and Dialysis最新文献

英文 中文
A study of cytotoxic effect of the uremic toxin indoxyl sulfate on myoblasts in vitro, the expression of myostatin mRNA in myoblast cell culture, and the possibility of exogenous regulation 体外研究尿毒症毒素硫酸吲哚酚对成肌细胞的细胞毒作用、培养成肌细胞中肌生长抑制素mRNA的表达及外源调控的可能性
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-2-219-224
V. A. Furalyov, V. Kukes, A. Gazdanova
{"title":"A study of cytotoxic effect of the uremic toxin indoxyl sulfate on myoblasts in vitro, the expression of myostatin mRNA in myoblast cell culture, and the possibility of exogenous regulation","authors":"V. A. Furalyov, V. Kukes, A. Gazdanova","doi":"10.28996/2618-9801-2021-2-219-224","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-2-219-224","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69397544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The vitamin D receptor - a new therapeutic target for kidney disease 维生素D受体——肾脏疾病的新治疗靶点
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-3-330-351
G. Volgina, N. A. Michailova, O. Kotenko
{"title":"The vitamin D receptor - a new therapeutic target for kidney disease","authors":"G. Volgina, N. A. Michailova, O. Kotenko","doi":"10.28996/2618-9801-2021-3-330-351","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-3-330-351","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69397839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spectrum of renal pathology: a 7-year review of renal biopsy database 肾病理谱:肾活检数据库的7年回顾
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-3-379-389
E. Stolyarevich, T. R. Zhilinskaja, V. V. Variasin, Artificial Organs
{"title":"Spectrum of renal pathology: a 7-year review of renal biopsy database","authors":"E. Stolyarevich, T. R. Zhilinskaja, V. V. Variasin, Artificial Organs","doi":"10.28996/2618-9801-2021-3-379-389","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-3-379-389","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69397950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe hypocalcemia - a problem of an early postoperative period after parathyroidectomy for secondary hyperparathyroidism in dialysis-dependent patients 严重的低钙血症——透析依赖患者继发性甲状旁腺功能亢进的甲状旁腺切除术后早期的一个问题
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-3-390-400
E. Parshina, P. Kislyy, K. Novokshonov, A. Tolkach, R. Chernikov, I. Karelina
{"title":"Severe hypocalcemia - a problem of an early postoperative period after parathyroidectomy for secondary hyperparathyroidism in dialysis-dependent patients","authors":"E. Parshina, P. Kislyy, K. Novokshonov, A. Tolkach, R. Chernikov, I. Karelina","doi":"10.28996/2618-9801-2021-3-390-400","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-3-390-400","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69399196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperparathyroidism in kidney transplant recipients: a single-center study 肾移植受者甲状旁腺功能亢进:一项单中心研究
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-3-401-413
O. Vetchinnikova, M. Clinical, A. Vatazin, M. Ivanova, R. O. Kantariya
{"title":"Hyperparathyroidism in kidney transplant recipients: a single-center study","authors":"O. Vetchinnikova, M. Clinical, A. Vatazin, M. Ivanova, R. O. Kantariya","doi":"10.28996/2618-9801-2021-3-401-413","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-3-401-413","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69398775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanisms of acute kidney injury in Covid-19. Review Covid-19急性肾损伤机制审查
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-3-352-365
L. Maltseva, I. Vasalatii, Y. Isaakyan, O. Morozova
The most important feature of acute kidney injury (AKI) in COVID-19 is the absence of a single main link of pathogenesis. A thorough understanding of the mechanisms and main links of the pathogenesis of the disease will allow the identifi cation of early markers of AKI, which will contribute to early diagnosis, prognosis, personalized therapy and prevention of kidney damage in patients with COVID-19. Aim: to summarize data from clinical and scientifi c studies on the known mechanisms of AKI in COVID- 19. To identify markers of early kidney injury in COVID-19. Materials and methods. In the Web of Science, Scopus and RSCI databases, 81 sources were selected that contained relevant data from clinical and scientifi c researches on the topic of this review. Results: the main reported mechanisms of kidney damage in COVID-19 patients are as follows: intracellular activity of the virus leading to cell death, excessive release of pro-infl ammatory cytokines and cytokine storm, pathology of the renin-angiotensin-aldosterone system (RAAS), hyperergic infl ammation and immunothrombosis. The main effects of angiotensin II in the case of dysregulation of the RAAS, as well as the spectrum of pro-infl ammatory cytokines and their functions in the development of the cytokine storm, were determined. The possibility of a direct cytopathic effect of SARS-CoV-2 on the renal epithelium as an independent cause of AKI in COVID-19 was considered. The association between the hyperergic infl ammatory response and the process of immunothrombosis, which is mediated by many defense systems, including neutrophils, platelets and proteins of the complement system was presented. The risk of thrombotic complications in the renal vessels in patients with COVID-19 was anaysed. An analysis of potential early biomarkers of kidney injury in COVID-19 were also presented and compared with clinical biomarkers of AKI. Conclusions: AKI is one of the most common complications in critically ill patients with COVID-19, which signifi cantly worsens the prognosis of the disease. The study of the mechanisms of kidney injury contributes to the discovery of new markers necessary for early diagnosis, prognosis of the course of the disease, and further determination of the optimal personalized therapy. © 2021 JSC Vidal Rus. All Rights Reserved.
COVID-19急性肾损伤(AKI)最重要的特征是缺乏单一的主要发病环节。深入了解疾病发病机制和主要环节,有助于发现AKI的早期标志物,有助于COVID-19患者的早期诊断、预后、个性化治疗和预防肾损害。目的:总结COVID- 19中AKI已知机制的临床和科学研究数据。目的:确定COVID-19患者早期肾损伤标志物。材料和方法。在Web of Science、Scopus和RSCI数据库中,我们选择了81个来源,这些来源包含了与本综述主题相关的临床和科学研究的相关数据。结果:报道的COVID-19患者肾损害的主要机制为:细胞内病毒活性导致细胞死亡、促炎细胞因子和细胞因子风暴过度释放、肾素-血管紧张素-醛固酮系统(RAAS)病理、超能性炎症和免疫血栓形成。在RAAS失调的情况下,血管紧张素II的主要作用,以及促炎症细胞因子的谱和它们在细胞因子风暴发展中的功能被确定。考虑到SARS-CoV-2对肾上皮的直接细胞病变作用可能是COVID-19患者AKI的独立原因。超能炎症反应与免疫血栓形成过程之间的关系,这是由许多防御系统介导的,包括中性粒细胞、血小板和补体系统的蛋白质。分析COVID-19患者肾血管血栓性并发症的风险。我们还分析了COVID-19肾脏损伤的潜在早期生物标志物,并与AKI的临床生物标志物进行了比较。结论:AKI是COVID-19危重症患者最常见的并发症之一,明显恶化疾病预后。对肾损伤机制的研究有助于发现早期诊断、病程预后和进一步确定最佳个性化治疗所需的新标志物。©2021 JSC Vidal Rus。版权所有。
{"title":"Mechanisms of acute kidney injury in Covid-19. Review","authors":"L. Maltseva, I. Vasalatii, Y. Isaakyan, O. Morozova","doi":"10.28996/2618-9801-2021-3-352-365","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-3-352-365","url":null,"abstract":"The most important feature of acute kidney injury (AKI) in COVID-19 is the absence of a single main link of pathogenesis. A thorough understanding of the mechanisms and main links of the pathogenesis of the disease will allow the identifi cation of early markers of AKI, which will contribute to early diagnosis, prognosis, personalized therapy and prevention of kidney damage in patients with COVID-19. Aim: to summarize data from clinical and scientifi c studies on the known mechanisms of AKI in COVID- 19. To identify markers of early kidney injury in COVID-19. Materials and methods. In the Web of Science, Scopus and RSCI databases, 81 sources were selected that contained relevant data from clinical and scientifi c researches on the topic of this review. Results: the main reported mechanisms of kidney damage in COVID-19 patients are as follows: intracellular activity of the virus leading to cell death, excessive release of pro-infl ammatory cytokines and cytokine storm, pathology of the renin-angiotensin-aldosterone system (RAAS), hyperergic infl ammation and immunothrombosis. The main effects of angiotensin II in the case of dysregulation of the RAAS, as well as the spectrum of pro-infl ammatory cytokines and their functions in the development of the cytokine storm, were determined. The possibility of a direct cytopathic effect of SARS-CoV-2 on the renal epithelium as an independent cause of AKI in COVID-19 was considered. The association between the hyperergic infl ammatory response and the process of immunothrombosis, which is mediated by many defense systems, including neutrophils, platelets and proteins of the complement system was presented. The risk of thrombotic complications in the renal vessels in patients with COVID-19 was anaysed. An analysis of potential early biomarkers of kidney injury in COVID-19 were also presented and compared with clinical biomarkers of AKI. Conclusions: AKI is one of the most common complications in critically ill patients with COVID-19, which signifi cantly worsens the prognosis of the disease. The study of the mechanisms of kidney injury contributes to the discovery of new markers necessary for early diagnosis, prognosis of the course of the disease, and further determination of the optimal personalized therapy. © 2021 JSC Vidal Rus. All Rights Reserved.","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69397853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The experience in applying the contrast-enhanced ultrasonography in successfully operated patient with malignant tumor of kidney transplant. Case Study and Review of Literature 超声造影在肾移植恶性肿瘤成功手术中的应用体会。个案研究与文献回顾
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-3-414-424
N. Belavina, R. Trushkin, E. Ivanova, L. Artyukhina, A. E. Lubennikov, D. Kantimerov, O. Manchenko, V. V. Varyasin, E. Stolyarevich, E. E. Berezhnaia, I. K. Maksimov, I. Kesareva, V. N. Smorshchok, N. Frolova, N. Vetsheva, Artificial Organs
{"title":"The experience in applying the contrast-enhanced ultrasonography in successfully operated patient with malignant tumor of kidney transplant. Case Study and Review of Literature","authors":"N. Belavina, R. Trushkin, E. Ivanova, L. Artyukhina, A. E. Lubennikov, D. Kantimerov, O. Manchenko, V. V. Varyasin, E. Stolyarevich, E. E. Berezhnaia, I. K. Maksimov, I. Kesareva, V. N. Smorshchok, N. Frolova, N. Vetsheva, Artificial Organs","doi":"10.28996/2618-9801-2021-3-414-424","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-3-414-424","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69399294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of «Gam-COVID-Vac» (Sputnik V) “Gam-COVID-Vac”(Sputnik V)的功效
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-3-434-436
A. D. Tolkach, Ekaterina Parshina, A. V. Ivanov, Pavel Kislyy
{"title":"Efficacy of «Gam-COVID-Vac» (Sputnik V)","authors":"A. D. Tolkach, Ekaterina Parshina, A. V. Ivanov, Pavel Kislyy","doi":"10.28996/2618-9801-2021-3-434-436","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-3-434-436","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69399302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 infection in kidney transplant recipients 肾移植受者的SARS-CoV-2感染
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-2-174-184
I. Kim, L. Artyukhina, N. Frolova, E. Ivanova, I. Ostrovskaya, V. Berdinsky, V. Vinogradov, E. Volodina, M.E. Maltseva, A. Stolbova, T. Buruleva, A. Frolov, E.A. Kalugin, I. Skryabina, D. Titov, N. Tomilina, M. Zubkin
The study aimed to assess the clinical course and risk factors for adverse outcomes, as well as the treatment options for COVID-19 in renal transplant recipient (RTR). Patients and methods: a retrospective study included 279 RTRs (M 60.9%, age 49.9±10.9 years), infected with SARS-CoV-2 from 01.04.2020 to 30.11.2020. After confirmation of COVID-19 by PCR and chest CT, MMF/Aza were canceled. In severe cases, the CNI dose was minimized while that of CS was increased. Observation endpoints: hospital discharge/recovery or death. Results: SARS-CoV-2 was identified in 84.2% of RTRs. In almost 90% of patients, the COVID-19 was confirmed by CT data. Duration after transplantation at the time of infection was 54.0 (14.0;108.0) months, in 17.6% of cases it was 6 months or less. 223/79.9% RTRs were treated in the hospital. The period from the onset of the disease to the hospitalization was 6.8±4.5 days. Severe lung damage (>50%) occurred in 43.1% RTRs;45.3% of patients required respiratory support. Hospital mortality was 13.9%, overall mortality was 11.1%. The most common cause of death (93.5%) was acute respiratory distress syndrome (ARDS). The risk factors associated with an unfavorable outcome were a high comorbidity index, the severity of the pulmonary lesion, the degree of graft dysfunction at the onset of the disease, decreased SpO2 and the use of mechanical ventilation, as well as anemia, leukocytosis, lymphocytopenia, and hypoalbuminemia, increased levels of creatinine, AST, CRP, LDH, and D-dimer, interleukin-6 and procalcitonin. Scr during the course of the disease increased from 171.6±78.0 μM to 221.5±121.3 μM (p<0.01) with no signs of acute rejection. In 2 recipients with severe graft failure at the time of infection with SARS-CoV-2, HD was resumed from the moment of hospitalization. We were unable to identify the effect of hydroxychloroquine on the outcome of COVID-19. At the same time, mortality in patients with hydroxychloroquine use was higher than in recipients treated with immunobiological drugs: 25.6% and 11.4%, respectively, p<0.02. When immunomodulators were combined with dexamethasone, mortality decreased to 4.8%. The independent factors of adverse outcome were high levels of procalcitonin (p<0.019) and mechanical ventilation (p<0.001). Conclusion: COVID-19 in RTRs is characterized by a severe course and high mortality, which necessitates hospitalization of the majority of infected patients. An increase in procalcitonin levels and the need for mechanical ventilation were independent predictors of an unfavorable outcome of COVID-19. © 2021 JSC Vidal Rus. All rights reserved.
本研究旨在评估肾移植受者(RTR)的临床病程和不良结局的危险因素,以及COVID-19的治疗方案。患者和方法:回顾性研究279例rtr(男性60.9%,年龄49.9±10.9岁),于2020年4月1日至2020年11月30日感染SARS-CoV-2。经PCR和胸部CT确认为COVID-19后,取消MMF/Aza。严重者尽量减少CNI剂量,增加CS剂量。观察终点:出院/康复或死亡。结果:SARS-CoV-2检出率为84.2%。在近90%的患者中,CT数据证实了COVID-19。移植后感染时间为54.0(14.0;108.0)个月,其中17.6%的病例感染时间为6个月及以下。223/79.9%的rtr患者在医院接受治疗。发病至住院时间为6.8±4.5 d。43.1%的RTRs发生严重肺损伤(>50%),45.3%的患者需要呼吸支持。住院死亡率为13.9%,总死亡率为11.1%。最常见的死亡原因(93.5%)是急性呼吸窘迫综合征(ARDS)。与不利结果相关的危险因素是高合并症指数、肺病变的严重程度、发病时移植物功能障碍的程度、SpO2降低和机械通气的使用,以及贫血、白细胞增多、淋巴细胞减少和低白蛋白血症、肌酐、AST、CRP、LDH和d -二聚体、白细胞介素-6和降钙素原水平升高。Scr在病程中由171.6±78.0 μM升高至221.5±121.3 μM (p<0.01),无急性排斥反应。在2例感染SARS-CoV-2时发生严重移植物衰竭的患者中,从住院时开始恢复HD。我们无法确定羟氯喹对COVID-19预后的影响。同时,羟氯喹组的死亡率高于免疫生物药物组,分别为25.6%和11.4%,p<0.02。当免疫调节剂与地塞米松联合使用时,死亡率降至4.8%。不良结局的独立因素为高降钙素原水平(p<0.019)和机械通气(p<0.001)。结论:RTRs新冠肺炎病程严重,病死率高,多数感染患者需住院治疗。降钙素原水平升高和机械通气需求是COVID-19不良结局的独立预测因素。©2021 JSC Vidal Rus。版权所有。
{"title":"SARS-CoV-2 infection in kidney transplant recipients","authors":"I. Kim, L. Artyukhina, N. Frolova, E. Ivanova, I. Ostrovskaya, V. Berdinsky, V. Vinogradov, E. Volodina, M.E. Maltseva, A. Stolbova, T. Buruleva, A. Frolov, E.A. Kalugin, I. Skryabina, D. Titov, N. Tomilina, M. Zubkin","doi":"10.28996/2618-9801-2021-2-174-184","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-2-174-184","url":null,"abstract":"The study aimed to assess the clinical course and risk factors for adverse outcomes, as well as the treatment options for COVID-19 in renal transplant recipient (RTR). Patients and methods: a retrospective study included 279 RTRs (M 60.9%, age 49.9±10.9 years), infected with SARS-CoV-2 from 01.04.2020 to 30.11.2020. After confirmation of COVID-19 by PCR and chest CT, MMF/Aza were canceled. In severe cases, the CNI dose was minimized while that of CS was increased. Observation endpoints: hospital discharge/recovery or death. Results: SARS-CoV-2 was identified in 84.2% of RTRs. In almost 90% of patients, the COVID-19 was confirmed by CT data. Duration after transplantation at the time of infection was 54.0 (14.0;108.0) months, in 17.6% of cases it was 6 months or less. 223/79.9% RTRs were treated in the hospital. The period from the onset of the disease to the hospitalization was 6.8±4.5 days. Severe lung damage (>50%) occurred in 43.1% RTRs;45.3% of patients required respiratory support. Hospital mortality was 13.9%, overall mortality was 11.1%. The most common cause of death (93.5%) was acute respiratory distress syndrome (ARDS). The risk factors associated with an unfavorable outcome were a high comorbidity index, the severity of the pulmonary lesion, the degree of graft dysfunction at the onset of the disease, decreased SpO2 and the use of mechanical ventilation, as well as anemia, leukocytosis, lymphocytopenia, and hypoalbuminemia, increased levels of creatinine, AST, CRP, LDH, and D-dimer, interleukin-6 and procalcitonin. Scr during the course of the disease increased from 171.6±78.0 μM to 221.5±121.3 μM (p<0.01) with no signs of acute rejection. In 2 recipients with severe graft failure at the time of infection with SARS-CoV-2, HD was resumed from the moment of hospitalization. We were unable to identify the effect of hydroxychloroquine on the outcome of COVID-19. At the same time, mortality in patients with hydroxychloroquine use was higher than in recipients treated with immunobiological drugs: 25.6% and 11.4%, respectively, p<0.02. When immunomodulators were combined with dexamethasone, mortality decreased to 4.8%. The independent factors of adverse outcome were high levels of procalcitonin (p<0.019) and mechanical ventilation (p<0.001). Conclusion: COVID-19 in RTRs is characterized by a severe course and high mortality, which necessitates hospitalization of the majority of infected patients. An increase in procalcitonin levels and the need for mechanical ventilation were independent predictors of an unfavorable outcome of COVID-19. © 2021 JSC Vidal Rus. All rights reserved.","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69396278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Renal dysfunction in patients with stage 1-2 arterial hypertension and its relationship with cardiovascular remodeling and vascular wall stiffness 1-2期高血压患者肾功能不全及其与心血管重构和血管壁硬度的关系
Pub Date : 2021-01-01 DOI: 10.28996/2618-9801-2021-2-185-191
E. Grigoricheva, Y. Bondareva, D. Matsuganov, O. Bastrikov, R. A. Abdulaev, E.V. Yarushina, V. V. Evdokimov
{"title":"Renal dysfunction in patients with stage 1-2 arterial hypertension and its relationship with cardiovascular remodeling and vascular wall stiffness","authors":"E. Grigoricheva, Y. Bondareva, D. Matsuganov, O. Bastrikov, R. A. Abdulaev, E.V. Yarushina, V. V. Evdokimov","doi":"10.28996/2618-9801-2021-2-185-191","DOIUrl":"https://doi.org/10.28996/2618-9801-2021-2-185-191","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69397486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nephrology and Dialysis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1